首页 工具
登录
购物车
Atrasentan hydrochloride

Atrasentan hydrochloride

产品编号 TQ0270   CAS 195733-43-8
别名: (+)-A 127722 hydrochloride, ABT-627 hydrochloride, 盐酸阿曲生坦, A-147627 hydrochloride

Atrasentan hydrochloride (ABT-627 hydrochloride) 是内皮素 A 受体选择性拮抗剂,抑制内皮素 A 受体活性的IC50为 0.0551 nM。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Atrasentan hydrochloride Chemical Structure
Atrasentan hydrochloride, CAS 195733-43-8
规格 价格/CNY 货期 数量
1 mg ¥ 428 现货
2 mg ¥ 617 现货
5 mg ¥ 947 现货
10 mg ¥ 1,390 现货
25 mg ¥ 2,820 现货
50 mg ¥ 3,970 现货
1 mL * 10 mM (in DMSO) ¥ 1,190 现货
其他形式的 Atrasentan hydrochloride:
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
重组蛋白限时优惠
产品目录号及名称: Atrasentan hydrochloride (TQ0270)
点击图片重新获取验证码
选择批次  
纯度: 98.64%
TargetMol batch loading
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Atrasentan hydrochloride (ABT-627 hydrochloride) is an antagonist of the endothelin receptor(IC50 = 55.1 μM for ETA).
靶点活性 ETA:55.1 μM
体外活性 Atrasentan(0-50 μM)显著抑制LNCaP和C4-2b前列腺癌细胞生长。ABT-627与Taxotere联合使用,相比单独使用任一药物,可显著降低前列腺癌活细胞的数量,并更大程度地下调NF-κB DNA结合活性[2]。Atrasentan显著诱导多种CYPs和药物转运体的表达。它是一种中等强度的P-gp抑制剂(IC50:15.1 μM,在P388/dx细胞中)和一种弱BCRP抑制剂(IC50:59.8 μM,在MDCKII-BCRP细胞中)[3]。
体内活性 Atrasentan(3 mg/kg, p.o.)通过抑制大型内皮素-1(1 nmol/kg)诱导的加压反应,在去髓大鼠中显示出效果[1]。此外,Atrasentan(10 mg/kg, i.p.)在SCID-hu模型中对C4-2b肿瘤在骨环境中的生长有一定程度的抑制作用[2]。
激酶实验 Cells are incubated and treated with Atrasentan. They are then washed twice with PBS and lysed in ice-cold lysis buffer [20 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium PPi, 1 mM β-glycerophosphate, 1 mM sodium orthovanadate, 1 μg/mL leupeptin, and 1 mM PMSF]. The extracts are centrifuged to remove cellular debris, and the protein content of the supernatants is determined using the bicinchoninic acid (BCA) protein assay reagent. Proteins (150 μg) are incubated with gentle rocking at 4°C overnight with immobilized Akt antibody cross-linked to agarose hydrazide beads. After the Akt is selectively immunoprecipitated from the cell lysates, the immunoprecipitated products are washed twice with lysis buffer and twice with kinase assay buffer [25 mM Tris (pH 7.5), 10 mM MgCl2, 5 mM β-glycerol phosphate, 0.1 mM sodium orthovanadate, 2 mM DTT] and then resuspended in 40 μL of kinase assay buffer containing 200 μM ATP and 1 μg GSK-3α/β fusion protein. The kinase assay reaction is allowed to proceed at 30°C for 30 min and stopped by the addition of Lamelli SDS sample buffer. Reaction products are resolved by 10% SDS-PAGE, followed by Western blotting with antiphosphorylated GSK-3α/β antibody. For analysis of the total amount of Akt, 40 μg of protein from the lysate samples are resolved by 10% SDS-PAGE, followed by Western blotting with anti-Akt antibody [2].
细胞实验 All three prostate cancer cell lines (LNCaP, C4-2b, and PC-3 cells) are seeded at a density of 3 × 10^3 cells per well in 96-well microtiter culture plates. After overnight incubation, the medium is removed and replaced with a fresh medium containing different concentrations of ABT-627 (0-50 μM) diluted from a 10-mM stock. After 72 h of incubation with the drug, 20 μL of MTT solution (5 mg/mL in PBS) is added to each well and incubated further for 2 h. Upon termination, the supernatant is aspirated and the MTT formazan formed by metabolically viable cells is dissolved in isopropanol (100 μL). The plates are mixed for 30 min on a gyratory shaker, and the absorbance is measured at 595 nm on a plate reader [2].
动物实验 YM598 (0.3, 1, and 3 mg/kg), atrasentan (0.3, 1, and 3 mg/kg), or 0.5% methylcellulose as vehicle is orally administered to rats with a dosing cannula. The dosing volume of the test substances and vehicle is set at 5 mL/kg. Approximately 20 min after administration of compounds, the rats are anesthetized with sodium pentobarbital, and then pithed and ventilated 30 min after dosing. Approximately 1 h after oral administration of compounds, big endothelin-1 (1 nmol/kg) is intravenously administered, and blood pressure is measured. In these two experiments, the dose of test compound that causes 50% inhibition (ID50) of the big endothelin-1-induced increase in diastolic blood pressure is determined by linear regression analysis [1].
别名 (+)-A 127722 hydrochloride, ABT-627 hydrochloride, 盐酸阿曲生坦, A-147627 hydrochloride
分子量 547.08
分子式 C29H39ClN2O6
CAS No. 195733-43-8

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

H2O: 0.4 mg/mL (0.73 mM), when pH is adjusted to 4 with HCl. Sonication and heating to 60℃ are recommended.

DMSO: 30 mg/mL (54.84 mM)

0.1 M HCL: < 1 mg/mL (insoluble), when pH is adjusted to 1 with HCl. Sonication and heating to 60℃ are recommended.

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.8279 mL 9.1394 mL 18.2789 mL 45.6972 mL
5 mM 0.3656 mL 1.8279 mL 3.6558 mL 9.1394 mL
10 mM 0.1828 mL 0.9139 mL 1.8279 mL 4.5697 mL
20 mM 0.0914 mL 0.457 mL 0.9139 mL 2.2849 mL
50 mM 0.0366 mL 0.1828 mL 0.3656 mL 0.9139 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Banerjee S, et al. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer. Cancer Res. 2007 Apr 15;67(8):3818-26. 2. Weiss J, et al. Interaction potential of the endothelin-A receptor antagonist atrasentan with drug transporters and drug-metabolising enzymes assessed in vitro. Cancer Chemother Pharmacol. 2011 Oct;68(4):1093-8. 3. Yuyama H, et al. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist. Eur J Pharmacol. 2004 Sep 13;498(1-3):171-7.
Endothelin 1 (swine, human) acetate Bosentan BMS 182874 Myriceric acid C Sitaxsentan sodium RO 46-8443 Sulfisoxazole Atrasentan

相关化合物库

该产品包含在如下化合物库中:
抑制剂库 抗癌药物库 膜蛋白靶向化合物库 抗癌临床化合物库 药物功能重定位化合物库 GPCR靶点分子库 神经递质受体化合物库 口服活性化合物库 经典已知活性库 临床期小分子药物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Atrasentan hydrochloride 195733-43-8 GPCR/G Protein Endothelin Receptor ABT-627 Hydrochloride (+)-A 127722 hydrochloride A 147627 A-147627 ABT-627 hydrochloride (+)-A 127722 A147627 Hydrochloride Atrasentan 盐酸阿曲生坦 A 147627 Hydrochloride ABT 627 Hydrochloride ABT627 Atrasentan Hydrochloride ABT-627 ABT 627 A-147627 Hydrochloride Inhibitor A-147627 hydrochloride A-127722 Hydrochloride ABT627 Hydrochloride A127722 Hydrochloride A 127722 Hydrochloride inhibit A147627 inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼